Covid-19

-

                    

As a leading publisher of trusted science, technology, medicine research, I committed to help public health authorities, researchers, clinicians and the general public to manage the spread of COVID-19. Following an outbreak of pneumonia, a novel strain of Corona virus (2019-nCoV) was detected in December 2019.

We have made the relevant research articles, special issues and entries in our major journals freely available below, in support of the global efforts in diagnosis, treatment, prevention and further research into COVID-19 and similar viral respiratory infections. Our approach is to use the world-class information we have available to directly improve health and to support the virtual efforts of healthcare practitioners globally. We also continue to work directly with our community to support teachers, lecturers, librarians, students and institutions in their work. We are continually monitoring the developments and we will update the content of this page periodically.



                                                                                  (COVID-19)
            
                                      Advances towards COVID-19

An epidemic of viral pneumonia, most probably caused by novel corona virus, has emerged in Wuhan, China, 2020. The causative agent was identified very swiftly during the course of the epidemic, but epidemiological situations have dynamically changed over time: initially, many cases were considered to have been linked to an exposure at a seafood market in Wuhan, but a massive number of cases have started to emerge not only in Wuhan city but across different cities in China and also in other well connected countries.

Many unknown characteristics of this disease remain. What kind of people is mainly affected? How does the clinical spectrum of this disease look like? Are transmissions from human to human taking place in the community and also in households? How long does it take from exposure to illness onset? How transmissible is the disease? When is the infectiousness highest during the course of infection? How severe is the infection, and what kind of people with underlying characteristics are particularly at high risk of death? To respond to the outbreak in a timely manner, it is vital that research responses to the outbreak focusing on above mentioned subjects are published in our Journal of Clinical Trials in a timely manner. This Special Issue will act as a publication media to attract many clinical and epidemiological studies on this outbreak, ensuring a fast turnaround time for high quality studies.


Potential topics include but are not limited to the following:

This Special Issues will cover original articles and review articles related to novel coronavirus COVID-19 clinical trials, antimicrobial resistance, social aspects and economic burden of disease, laboratory identification, community interventions, GIS application, and mathematical models. Topics include but not limited to;

Clinical trials, Global burden, Disability-adjusted life years (DALY), Risk factors, Community interventions, Laboratory studies, Drug resistance, GIS applications, Cost-effective analysis, Vaccine, Mathematical models, Social epidemiology, Modeling & environmental epidemiology, Extreme Weather, Seasonality, Environmental Monitoring, Disease Tracking, Surveillance Systems, Public Health and Environmental Policies.

Comments

Post a Comment

Medical Health Sciences

Popular posts from this blog

STUDY OF UGIT (P-14)

-
Image
  14- Obesity An estimated 60 percent of Americans aged 20 years and older are considered overweight and one-quarter are considered obese. Being overweight means that you have an excess amount of body weight, including muscle, bone, fat and water. Being obese means that you have an excess amount of body fat. Obesity significantly increases your risk of developing life-threatening conditions, such as heart disease, stroke, high blood pressure, type 2 diabetes and some forms of cancer. Each year, approximately 280,000 adults die from an obesity-related condition in the United States. Additionally, studies have shown that people who are overweight often suffer from societal discrimination, which may lead to depression, self-esteem and body issue problems. Causes of Obesity Obesity is a complex and chronic disease with many causes. It is not simply a result of overeating. Research has shown that genetics can play a significant role in determining a person's body weight, particula...
Read more

Basic Components of the Immune System

-
Image
INTRODUCTION      It is generally believed that the immune system evolved as the host’s defense against infectious agents, and it is well known that patients with deficiencies in the immune system generally succumb to these infectious diseases. However, as we shall see, it may well play a larger role in the elimination of other foreign substances, including tumor antigens or cells and antibodies that attack self. An immune response may be conveniently divided into two parts:  1) a specific response to a given antigen and  2) a more nonspecific augmentation to that response.       An important feature of the specific response is that there is a quicker response to the antigen during a second exposure to that antigen. It is the memory of the initial response that provides the booster effect. For convenience, the specific immune response may be divided into two parts:  1) the humoral response and  2) ...
Read more

Pulmonary Hypertension

-
Image
WHO Classification of Pulmonary Hypertension Group I. Pulmonary Arterial Hypertension Idiopathic primary Familial and related Disorders collagen vascular disease, congenital systemic to pulmonary shunts, portal hypertension, HIV, drugs and toxins, thyroid disorders, glycogen storage disease, Gaucher’s disease, hereditary hemorrhagic telangiectasia, hemoglobinopa thies, myeloproliferative disorders, splenectomy Associated with Significant Venous or Capillary Involvement pulmonary venoocclusive disease, pulmonary capillary hemangiomatosis Persistent Pulmonary Hypertension of Newborn Group II. Pulmonary venous Hypertension left sided atrial or ventricular heart disease, left sided valvular heart disease Group III. Pulmonary Hypertension associated with Hypoxemia COPD, interstitial lung disease, sleep disordered breathing, alveolar hypoventilation disorders, chronic exposure to high altitude, developmental abnormalities Group IV. Pulmonary Hypertension due to chronic Thromb...
Read more